InfuSystems Holdings (InfuSystems Holdings) Change In Working Capital : $-3.9 Mil (TTM As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is InfuSystems Holdings Change In Working Capital?

InfuSystems Holdings's change in working capital for the quarter that ended in Mar. 2024 was $-1.5 Mil.

InfuSystems Holdings's change in working capital for the fiscal year that ended in Dec. 2023 was $-5.6 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

InfuSystems Holdings Change In Working Capital Historical Data

The historical data trend for InfuSystems Holdings's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InfuSystems Holdings Change In Working Capital Chart

InfuSystems Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

Get a 7-Day Free Trial

-0.19

-1.27

-2.69

0.39

-5.56

InfuSystems Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Working Capital	Get a 7-Day Free Trial															-3.15	-2.14	-0.70	0.43	-1.50

InfuSystems Holdings Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.9 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

InfuSystems Holdings Change In Working Capital Related Terms

Thank you for viewing the detailed overview of InfuSystems Holdings's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

InfuSystems Holdings (InfuSystems Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InfuSystems Holdings Inc (AMEX:INFU) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

1TZ:Germany

Address

3851 West Hamlin Road, Rochester Hills, MI, USA, 48309

Website

http://www.infusystem.com

InfuSystems Holdings Inc is a United States based healthcare service provider. It offers Infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from the locations in the United States and Canada. The company provides products and services to hospitals, oncology practices and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The segments of the company are Integrated Therapy Services (ITS) and Durable Medical Equipment (DME) services, of which key revenue is derived from the ITS segment.

Executives

Jerod Funke	officer: EVP-Chief HR Officer	3851 WEST HAMLIN RD, ROCHESTER HILLS MI 48309
R. Rimmy Malhotra	director	C/O COMMAND CENTER, INC., 3609 S WADSWORTH BLVD., SUITE 250, LAKEWOOD CO 80235
Gregg Owen Lehman	director	309 HADDON COURT, FRANKLIN X1 37067
Richard Dilorio	officer: Executive Vice President	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Barry G Steele	officer: Executive VP and CFO	500 TOWN CENTER DR., SUITE 200, DEARBORN MI 48126
Carrie Lachance	officer: Executive VP and COO	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Christopher R. Sansone	director	C/O SANSONE ADVISORS, LLC, 151 BODMAN PLACE, SUITE 100, RED BANK NJ 07701
Addam Chupa	officer: Executive VP and CIO	3851 WEST HAMLIN ROAD, ROCHESTER HILLS MI 48309
Kevin Whitman	officer: VP and Corporate Controller	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Thomas Mark Ruiz	officer: VP of Sales and Marketing	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Boyd Ralph F Jr	director
Paul Andrew Gendron	director	740 BANDIT TRAIL, KELLER TX 76248
Jeannine Sheehan	officer: Chief Administrative Officer	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Blueline Capital Partners Ii, L.p.	director	3480 BUSKIRK AVENUE, SUITE 214, PLEASANT HILL CA 94523
Meridian Tsv Ii, Lp	10 percent owner	405 WEED STREET, NEW CANAAN CT 06840